About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
GMED - Globus Medical| Previous Close | $53.67 | Open | $53.19 |
| Volume | 451.6K | Market Cap | 5.239B |
| Yield | Last Dividend |
| Lumbar Disc Herniation Treatment Market ... | 9:06 AM |
| Lumbar disc herniation treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses... | |
| Brokerages Anticipate Globus Medical, In... | 10/22/20 |
| Brokerages predict that Globus Medical, Inc. (NYSE:GMED) will report sales of $197.71 million for the current quarter, Zacks reports. Six analysts hav... | |
| MORGAN STANLEY: Buy these 61 stocks that... | 10/21/20 |
| Summary List Placement When it comes to his outlook on the market for the next few months, Morgan Stanley's Mike Wilson is pessimistic. The bank's chi... | |
| Globus Medical (GMED) Set to Announce Qu... | 10/20/20 |
| Globus Medical (NYSE:GMED) will post its quarterly earnings results after the market closes on Wednesday, October 28th. Analysts expect Globus Medical... | |
| Globus Medical Schedules Third Quarter 2... | 10/16/20 |
| AUDUBON, Pa., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its??? | |
| Cervical Total Disc Replacement Device M... | 10/09/20 |
| "Cervical Total Disc Replacement Device Market??? Report evaluated the historical and current performance of the market, especially highlighting the k... | |
| Cervical Total Disc Replacement Device M... | 10/05/20 |
| "Cervical Total Disc Replacement Device Market??? Report evaluated the historical and current performance of the market, especially highlighting the k... | |
| Global Vertebroplasty and Kyphoplasty Ma... | 10/01/20 |
| A new research study from ???Data Bridge Market Research??? with title Vertebroplasty and Kyphoplasty Insights 2020, Global Analysis and Forecast to 2... | |
| Orthopedic Biomaterials Market to Reach ... | 09/30/20 |
| The current report on the Orthopedic Biomaterials Market provides a comprehensive assessment of the business vertical and offers a comprehensive overv... | |
| Global Spinal Fusion Market 2015-2030: K... | 08/12/20 |
| DUBLIN--(BUSINESS WIRE)--The "Spinal Fusion (Orthopedic Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been... | |
| Worldwide Interventional Spine Devices M... | 08/05/20 |
| DUBLIN--(BUSINESS WIRE)--The "Global Interventional Spine Devices Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The in... | |
| Globus Medical Schedules Second Quarter ... | 07/21/20 |
| AUDUBON, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its??? | |
| Globus Medical Inc (NYSE: GMED) Q1 2020 ... | 06/26/20 |
| Globus Medical Inc (NYSE: GMED) Q1 2020 Earnings Conference Call Final Transcript | |
| COVID-19: Significant Shift in Strategy ... | 06/25/20 |
| Technavio has been monitoring the orthopedic implants market and it is poised to grow by USD 10.09 billion during 2020-2024, progressing at a CAGR of ... | |
| Globus Medical Faces Business Loss Amid ... | 06/09/20 |
| Globus Medical (GMED) notes that the U.S. spine business bottomed in the first full week of April, witnessing a decline of about 70% from its pre-COVI... | |
| Globus Medical (GMED) Misses on Q1 Earni... | 05/08/20 |
| Globus Medical (GMED) witnesses around $20 million of COVID-19 related adverse impact on its Q1 sales. | |
| Globus Medical (GMED) Lags Q1 Earnings a... | 05/07/20 |
| Globus Medical (GMED) delivered earnings and revenue surprises of -27.50% and -4.65%, respectively, for the quarter ended March 2020. Do the numbers h... | |
| Why Is Globus Medical (GMED) Down 28.9% ... | 03/21/20 |
| Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| BTIG Buys Into Globus Medical's Longer-T... | 03/18/20 |
| Globus Medical Inc???s (NYSE: GMED ) shares have declined around 33% from their year-end 2019 high, and the company has a strong balance sheet that ca... | |
| Global Spinal Implants Market 2020-2024 ... | 02/25/20 |
| LONDON--(BUSINESS WIRE)-- #GlobalSpinalImplantsMarket--The global spinal implants market is poised to grow by USD 2.75 billion during 2020-2024 | |
| Stock Alert: Globus Medical (GMED) | 02/12/20 |
| Globus Medical Inc. (GMED) is all set to announce its financial results for the fourth quarter and full-year ended December 31, 2019, after the market... | |
| Globus Medical Gains From International ... | 01/16/20 |
| Globus Medical (GMED) delivers solid spine sales globally. Enabling Technologies too rides high on the rising uptake of ExcelsiusGPS platform. | |
| The Daily Biotech Pulse: Axovant Surges ... | 12/20/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs D... | |
| Here's Why You Should Hold on to Globus ... | 12/19/19 |
| Investors continue to be optimistic about Globus Medical (GMED) on its stellar segmental performance. | |
| The Daily Biotech Pulse: Positive Adcom ... | 12/18/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 17) ... | |
| The Daily Biotech Pulse: Second Time's T... | 12/13/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: ASH Meeting Wra... | 12/10/19 |
| The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 9.) Acce... | |
| Why Is Globus Medical (GMED) Up 3.9% Sin... | 12/06/19 |
| Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| The Daily Biotech Pulse: Tonix Says No S... | 11/27/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 26) ... | |
| The Daily Biotech Pulse: ChemoCentryx Tr... | 11/26/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.... | |
| Hold rating | 10/20/20 |
| Stifel initiates coverage with Hold rating and announces Price Target of $56.00 | |
| Strong Buy rating | 08/06/20 |
| SVB Leerink maintains Outperform rating and raises Price Target from $56.00 to $64.00 | |
| Buy rating | 08/06/20 |
| Needham maintains Buy rating and raises Price Target from $60.00 to $65.00 | |
| Hold rating | 08/06/20 |
| Morgan Stanley maintains Equal-Weight rating and raises Price Target from $52.00 to $58.00 | |
| Strong Buy rating | 08/06/20 |
| Credit Suisse maintains Outperform rating and raises Price Target from $57.00 to $58.00 | |
| Buy rating | 08/06/20 |
| Canaccord Genuity maintains Buy rating and raises Price Target from $56.00 to $60.00 | |
| Hold rating | 08/06/20 |
| Piper Sandler maintains Neutral rating and raises Price Target from $50.00 to $55.00 | |
| Strong Buy rating | 08/06/20 |
| Wells Fargo maintains Overweight rating and raises Price Target from $54.00 to $56.00 | |
| Date | 2020-08-05 (AMC) | Est. (EPS/Rev.) | ($0.11)/ 99.73M |
| Actual (EPS/Rev.) | $0.07/ $148.92 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| TopFlight Trades - Premium (Options) | Eric Cunningham | 51.00 % | Follow |
| TopFlight Trades - Premium (Stocks) | Eric Cunningham | 38.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
